Achieving selectivity between highly homologous tyrosine kinases: a novel selective erbB2 inhibitor.

Saved in:
Bibliographic Details
Title: Achieving selectivity between highly homologous tyrosine kinases: a novel selective erbB2 inhibitor.
Authors: Bhattacharya SK; Pfizer Global Research and Development, Cancer Drug Discovery, Groton, CT 06340, USA., Cox ED, Kath JC, Mathiowetz AM, Morris J, Moyer JD, Pustilnik LR, Rafidi K, Richter DT, Su C, Wessel MD
Source: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2003 Jul 25; Vol. 307 (2), pp. 267-73.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0372516 Publication Model: Print Cited Medium: Print ISSN: 0006-291X (Print) Linking ISSN: 0006291X NLM ISO Abbreviation: Biochem Biophys Res Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0006-291X
DOI:10.1016/s0006-291x(03)01160-4